Features of structural and geometric cardiac remodeling in patients with diabetes mellitus depending on chronic kidney disease stages
Open Access
- 30 March 2024
- journal article
- research article
- Published by Gomel State Medical University in Health and Ecology Issues
- Vol. 21 (1) , 49-58
Abstract
Objective. To study the features of structural and geometric cardiac remodeling in patients with diabetes mellitus (DM) depending on the stage of chronic kidney disease (CKD). Materials and methods. We examined 499 patients (127 men and 322 women) with type 1 DM (133 people) and type 2 DM (316 people) aged 62 [52;69] years. The comparison group consisted of 65 randomly selected volunteering individuals (54 women and 11 men) without disorders of carbohydrate metabolism and kidney damage aged 59 [46;66] years. The laboratory examination of the patients included the measurement of serum creatinine, eGFR according to the CKD-EPI equation. An echocardiographic investigation was performed to study structural and geometric heart parameters. Left ventricular hypertrophy (LVH) was diagnosed when the left ventricular myocardial mass index (LVMI) exceeded 115 g/m2 in men and 95 g/m2 in women. Results. LVH was detected in 57.7 % of patients with DM, while in the comparison group – in 35.4 %. The frequency of LVH increased with a decrease in eGFR and was diagnosed in 100 % of cases with CKD 5. In patients with DM, the left ventricular concentric remodeling significantly predominated (29.2%). Multiple linear regression analysis demonstrated the influence of age (ß=0.30, p=0.01) and serum creatinine (ß = 0.15, p < 0.0001) on the LVMI, independent of other factors, which confirms their independent pathogenetic significance. Conclusion. Thus, patients with DM regardless of the CKD stage have structural and functional changes in the LV myocardium. Regardless of the nitrogen-excretion function of the kidneys, the predominant pattern of LV remodeling is concentric. The study of the features of structural and functional restructuring of the left heart in patients with diabetes should be taken into account in determining the cardiovascular prognosis.Keywords
This publication has 21 references indexed in Scilit:
- Cardiac metabolic remodelling in chronic kidney diseaseNature Reviews Nephrology, 2022
- Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imagingNature Reviews Cardiology, 2020
- Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidenceNature Reviews Cardiology, 2020
- Coronary microvascular dysfunction in hypertrophy and heart failureCardiovascular Research, 2020
- Left ventricular hypertrophy and hypertensionProgress in Cardiovascular Diseases, 2020
- Is Left Ventricular Hypertrophy a Valid Therapeutic Target?Current Hypertension Reports, 2019
- Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and preventionThe Lancet, 2013
- Differential impact of left ventricular mass and relative wall thickness on cardiovascular prognosis in diabetic and nondiabetic hypertensive subjectsAmerican Heart Journal, 2007
- Cardiovascular morbidity and mortality in patients with diabetes in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenololACC Current Journal Review, 2002
- Impact of age on echocardiographic left ventricular mass in a healthy population (the Framingham study)The American Journal of Cardiology, 1989